Delivery Order SPE2DR25D3501-SPE2DR26FL8UD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,097.08 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 mL vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Docetaxel 80 mg/4 mL vials valued at $1,093.69. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order on July 24, 2025, by the Defense Logistics Agency's Medical Supply Chain to deliver Docetaxel 160 mg/8 ml vials with a ceiling value of $2,267.90 and an ultimate completion date of July 25, 2025. The award is unclassified and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,434.04 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 ml vials on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract covers the delivery of this pharmaceutical product to support federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,387.22, is for the supply of 4,564,688,768 mL of the pharmaceutical product Docetaxel 160 mg/16 mL. The order has a firm fixed-price pricing type and a completion date of May 23, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 160 mg/16 ml docetaxel vials. The contract has a ceiling value of $2,800.08 and runs from August 2022 to August 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide...
- The Defense Logistics Agency awarded a $439,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561288641, which is described as Docetaxel 160 MG/8 ML VIAL 8ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from June 20, 2023 to June 21, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports...
- The Defense Logistics Agency awarded a $3,761.82 delivery order to Amerisourcebergen Drug Corp for the supply of 4562082718, described as DOCETAXEL 80 MG/8 ML VIAL 8ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania under firm fixed pricing within the period of performance of September 7-8, 2023. The parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $149,340 to Amerisourcebergen Drug Corporation to supply docetaxel, an oncology drug, for one day's performance in Conshohocken, Pennsylvania. As a prime contractor on the Defense Logistics Agency's Prime Vendor program, which covers pharmaceuticals and other medical commodities for the Department of Defense, Amerisourcebergen will deliver the chemotherapy medication from its distribution center to support DOD...
- The Defense Logistics Agency awarded a delivery order valued at $4,467.19 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL8UDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,907.43 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 ml vials on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's substantial IDC with the Defense Logistics Agency functions as a comprehensive global pharmaceutical support vehicle, enabling the supply of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for Docetaxel, a chemotherapy agent used in cancer treatment, exemplifies the specialized pharmaceutical commodities that the contractor routinely furnishes through its extensive federal contract portfolio with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/17/25 |